Documento fuente o registro público

FDA 510(k) K260447 — ETEST Gepotidacin (GEP) (0.016-256 µg/mL)

FDA 510(k) index record K260447. Device: ETEST Gepotidacin (GEP) (0.016-256 µg/mL). Applicant as listed: bioMérieux SA. Decision date: 2026-04-21.

OtherU.S. Food and Drug Administration (FDA)2026-04-21

Fuente

"device_name": "ETEST Gepotidacin (GEP) (0.016-256 µg/mL)"

Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-23

Disclaimer

professional use

FDA 510(k) public index record K260447.

Device name: ETEST Gepotidacin (GEP) (0.016-256 µg/mL). Applicant as listed: bioMérieux SA.

Decision date: 2026-04-21. Decision wording: Substantially Equivalent.

Product code: JWY. Regulation: 21 CFR 866.1640. Medical specialty: Microbiology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.

Explorar más